International Stem Cell Corporation
ISCO
$0.1457
-$0.0163-10.06%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.94% | -12.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.94% | -12.96% | |||
| Cost of Revenue | -6.55% | 0.20% | |||
| Gross Profit | 33.69% | -21.91% | |||
| SG&A Expenses | 2.23% | -28.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.73% | -2.13% | |||
| Operating Income | 177.67% | -521.57% | |||
| Income Before Tax | 150.39% | -2,427.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 150.39% | -2,427.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 150.39% | -2,427.27% | |||
| EBIT | 177.67% | -521.57% | |||
| EBITDA | 238.13% | -252.38% | |||
| EPS Basic | 126.25% | -2,385.71% | |||
| Normalized Basic EPS | 150.50% | -2,322.22% | |||
| EPS Diluted | 126.25% | -2,385.71% | |||
| Normalized Diluted EPS | 150.50% | -2,322.22% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||